ERBB2 and liver cancer: We found evidence for a causal effect of higher genetically predicted liver fat on increased liver cancer risk, higher genetically predicted pancreas fat on increased endometrioid ovarian cancer risk, and higher genetically predicted ASAT on decreased luminal B/HER2-negative-like and triple-negative or basal-like breast cancer risk.